Clinical Trial: Vitamin K Antagonist in Rheumatic Heart Disease Patients With Mechanical Heart Valves: Our Current Status

U.S., Aug. 29 -- ClinicalTrials.gov registry received information related to the study (NCT07146282) titled 'Vitamin K Antagonist in Rheumatic Heart Disease Patients With Mechanical Heart Valves: Our Current Status' on Aug. 04.

Brief Summary: VKA in RHD patients with MHV: our current status

Study Start Date: Sept., 2025

Study Type: OBSERVATIONAL

Condition: Rheumatic Heart Disease

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Ahmed Hassan Rostom Ibrahim

Information provided by (Responsible Party): Ahmed Hassan Rostom Ibrahim, Assiut University

Disclaimer: Curated by HT Syndication....